Eagle Health Investments LP Q4 2024 Filing

Filed February 12, 2025

Portfolio Value

$407.9B

Holdings

18

Report Date

Q4 2024

Filing Type

13F-HR

All Holdings (18 positions)

#	Stock	Shares	Value	% Portfolio	Type
1	NTRANATERA INC	339,764	$53.8M	0.01%
2	ARGXARGENX SE	74,990	$46.1M	0.01%
3	ILMNILLUMINA INC	343,361	$45.9M	0.01%
4	ICLRICON PLC	209,190	$43.9M	0.01%
5	IM8NINSMED INC	513,700	$35.5M	0.01%
6	BMRNBIOMARIN PHARMACEUTICAL INC	419,212	$27.6M	0.01%
7	RAREULTRAGENYX PHARMACEUTICAL IN	627,600	$26.4M	0.01%
8	INSPINSPIRE MED SYS INC	136,603	$25.3M	0.01%
9	DC4DEXCOM INC	274,551	$21.4M	0.01%
10	NBIXNEUROCRINE BIOSCIENCES INC	155,000	$21.2M	0.01%
11	PRCTPROCEPT BIOROBOTICS CORP	233,089	$18.8M	0.00%
12	ALNYALNYLAM PHARMACEUTICALS INC	76,256	$17.9M	0.00%
13	AGIOAGIOS PHARMACEUTICALS INC	330,830	$10.9M	0.00%
14	UTHUNITED THERAPEUTICS CORP DEL	21,802	$7.7M	0.00%
15	ISRGINTUITIVE SURGICAL INC	4,390	$2.3M	0.00%
16	IMCRIMMUNOCORE HLDGS PLC	46,300	$1.4M	0.00%
17	TMDXTRANSMEDICS GROUP INC	18,061	$1.1M	0.00%
18	GRALGRAIL INC	53,124	$948K	0.00%